Eyelid injection shows promise for thyroid eye disease symptoms
NCT ID NCT07471997
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether injecting triamcinolone acetonide into the eyelid could help people with thyroid eye disease who have a retracted upper eyelid. Fifteen adults received a combination of two injections and were measured one month later. The goal was to see if the eyelid position improved, which could ease eye discomfort and cosmetic concerns.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- triamcinolone acetonide
- What this could lead to
- If it works, this could offer a simple injection to improve eyelid position and reduce eye discomfort in people with thyroid eye disease.
- What could go wrong
- This is a very small, early study with only 15 people and no comparison group. Results may not apply to everyone, and the effect may be temporary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID EYE DISEASE, TED are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Instituto de Oftalmologia F.A.P. Conde de Valenciana, I.A. P.
Mexico City, Mexico
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a pill reverse eye bulging in thyroid eye disease?
- Could your Phone's camera help track thyroid eye disease?
- New drug aims to ease bulging eyes in thyroid disease patients
- New drug MHB018A aims to reduce eye bulging in thyroid eye disease
- New shot aims to reduce bulging eyes from thyroid disease
- New pill could help when steroids fail for bulging eyes